[Pathopharmacologic models of cerebral disorders].
D000375:Aging; D000818:Animals; D001161:Arteriosclerosis / Q000503:physiopathology*; D002560:Cerebrovascular Circulation; D003704:Dementia / Q000503:physiopathology*; D004088:Dihydroergotoxine / Q000627:therapeutic use; D004195:Disease Models, Animal; D004285:Dogs; D004734:Energy Metabolism; D005947:Glucose / Q000378:metabolism; D006801:Humans; D002534:Hypoxia, Brain / Q000503:physiopathology*; D008568:Memory / Q000187:drug effects; D009474:Neurons / Q000378:metabolism; D010313:Partial Pressure; D011817:Rabbits; D014749:Vincamine / Q000627:therapeutic use
D004088:Dihydroergotoxine; D014749:Vincamine; D005947:Glucose
Pathopharmakologische Modelle zerebraler Störungen.